Expression and display of glycoengineered antibodies and antibody fragments with an engineered yeast strain

7Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

Interactions with cell surface receptors enhance the therapeutic properties of many im-portant antibodies, including the low-affinity Fc γ Receptors (FcγRs). These interactions require proper processing of the immunoglobulin G Fc N-glycan, and eliminating the N-glycan abolishes binding, restricting antibody production to mammalian expression platforms. Yeasts, for example, generate extensively mannosylated N-glycans that are unsuitable for therapeutics. However, Fc with a specifically truncated N-glycan still engages receptors with considerable affinity. Here we describe the creation and applications of a novel Saccharomyces cerevisiae strain that specifically modifies the IgG1 Fc domain with an N-glycan consisting of a single N-acetylglucosamine residue. This strain displayed glycoengineered Fc on its surface for screening yeast surface display libraries and also served as an alternative platform to produce glycoengineered Rituximab. An IgG-specific endo-glycosidase (EndoS2) truncates the IgG1 Fc N-glycan. EndoS2 was targeted to the yeast ER using the signal peptide from the yeast protein disulfide isomerase (PDI) and a yeast ER retention signal (HDEL). Furthermore, >99% of the yeast expressed Rituximab displayed the truncated glycoform as determined by SDS-PAGE and ESI-MS analyses. Lastly, the yeast expressed Rituximab engaged the FcγRIIIa with the expected affinity (KD = 2.0 ± 0.5 µM) and bound CD20 on Raji B cells.

References Powered by Scopus

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

2744Citations
N/AReaders
Get full text

Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity

1556Citations
N/AReaders
Get full text

Yeast surface display for screening combinatorial polypeptide libraries

1439Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Challenges and progress towards industrial recombinant protein production in yeasts: A review

41Citations
N/AReaders
Get full text

Humanization of Yeasts for Glycan-Type End-Products

6Citations
N/AReaders
Get full text

Metabolic<sup>15</sup>N labeling of the N-glycosylated immunoglobulin G1 Fc with an engineered Saccharomyces cerevisiae strain

3Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Shenoy, A., Yalamanchili, S., Davis, A. R., & Barb, A. W. (2021). Expression and display of glycoengineered antibodies and antibody fragments with an engineered yeast strain. Antibodies, 10(4). https://doi.org/10.3390/antib10040038

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 9

60%

Researcher 5

33%

Professor / Associate Prof. 1

7%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 10

71%

Chemical Engineering 2

14%

Chemistry 1

7%

Agricultural and Biological Sciences 1

7%

Save time finding and organizing research with Mendeley

Sign up for free